Atlas FDA

Ellipse DR and Ellipse VR

FDA premarket approval P910023/S426 · decided 2020-03-13

Approval details

PMA number
P910023
Supplement
S426
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Ellipse DR and Ellipse VR
Generic name
Implantable cardioverter defibrillator (non-CRT)
Applicant
ABBOTT MEDICAL
Date received
2020-02-18
Decision date
2020-03-13
Days to decision
24 days
Decision code
OK30
Product code
LWS
Advisory committee
Cardiovascular
Expedited review
No
Location
Sylmar, CA
Statement
Alternate supplier of the battery boot component and change to an in-house application of the heat shield tape to the battery boot assembly used in Ellipse DR and VR ICD devices.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
EnSite™ X EP System (K262006)Abbott Medical2026-07-15
Amplatzer TorqVue Exchange System (K261631)Abbott Medical2026-06-17
OPTIS Mobile Next Imaging System (1014932); OPTIS Integrated Next Imaging System (1014933); Ultreon 3.0 Software Upgrade Kit (ULTR300001) (K253459)ABBOTT MEDICAL2026-04-24
EnSite™ X EP System (K260212)ABBOTT MEDICAL2026-04-20
Disposable Radiofrequency Cannula (K253907)ABBOTT MEDICAL2026-04-16
Amplatzer™ Trevisio™ Intravascular Delivery System; 9-ATV06F45/609-ATV07F45/609-ATV07F45/809-ATV08F45/609-ATV08F45/809-ATV09F45/809-ATV10F45/809-ATV12F45/80 (K260499)ABBOTT MEDICAL2026-03-13
Armada™ 14 NC PTA Catheter (K252512)ABBOTT MEDICAL2026-02-13
Assert-IQ (DM5100) (K253516)ABBOTT MEDICAL2025-12-18